http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2366375-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_6861fb8efac70a51a6b2a3d23f2032e8
classificationCPCAdditional http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2800-78
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-4926
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-498
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-416
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-1075
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-127
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K8-347
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-49
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-41
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-34
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K8-14
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61Q19-00
filingDate 2011-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01ff8b0bbea64af6225e672c7d125938
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bcf9f1734ee07046c6ae465c2af99d47
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_19c9d217e53f41fd2c32ec14916f70f8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f00b8e632c75cc8b09abcf02fd200458
publicationDate 2015-09-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber EP-2366375-A3
titleOfInvention Composition with a sirtuin activator
abstract The present invention relates to a composition comprising at least one sirtuin activator, preferably selected from quercitin, piceatannol, resveratrol and isonicotinamide, and having a carrier system for the at least one sirtuin activator, wherein the carrier system comprises lipid vesicles with one or more lipid membrane (s). In order to provide an improved effect of sirtuin activators in living skin cells, it is proposed according to the invention that the at least one sirtuin activator is contained in the lipid vesicles and the lipid vesicles have a positive surface charge, wherein the positive surface charge is caused by the Lipid vesicles in the / the lipid membrane / s in addition to the lipids of which the vesicles are composed of positively charged molecules as charge generators, these charge generators are selected from quaternary ammonium compounds.
priorityDate 2010-03-17-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/JP-2009161494-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2005136537-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2906139-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-2010022661-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1723958-A2
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID667639
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID15074
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129116523
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5280343
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID445154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419482810
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419476111
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129468261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226427939
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409174
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID451009043
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518543
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID77146876

Total number of triples: 46.